Advagene Biopharma Co., Ltd. (TPEX:6709)
31.75
+0.15 (0.47%)
At close: Feb 11, 2026
59.15% (1Y)
| Market Cap | 1.89B +54.5% |
| Revenue (ttm) | n/a |
| Net Income | -71.10M |
| EPS | -1.23 |
| Shares Out | 59.38M |
| PE Ratio | n/a |
| Forward PE | n/a |
| Dividend | n/a |
| Ex-Dividend Date | n/a |
| Volume | 20,922 |
| Average Volume | 136,053 |
| Open | 31.90 |
| Previous Close | 31.60 |
| Day's Range | 31.10 - 31.95 |
| 52-Week Range | 15.75 - 41.00 |
| Beta | 0.78 |
| RSI | 55.70 |
| Earnings Date | Mar 20, 2026 |